Clarification: PILA PHARMA SPONSORS INTERNATIONAL DIABETES & NUTRITION CONFERENCE Dispatch missing first section with scientific meeting information. PILA PHARMA today announces it's participation in and co-sponsorship of the 41st International Symposium on D...
PILA PHARMA SPONSORS INTERNATIONAL DIABETES & NUTRITION CONFERENCE PILA PHARMA today announces it's participation in and co-sponsorship of the 41st International Symposium on Diabetes and Nutrition, organized by the Diabetes and Nutrition Study...
PILA PHARMA PRESENTS TOMORROW AT "AKTIESPARARNA" PILA PHARMA AB (publ) (FN STO: PILA) announces that it will present tomorrow at the Aktiespararna's "Store Aktiedagarna" event.
PILA PHARMA PRESENTS TODAY AT REDEYE THEME: DIABETES PILA PHARMA AB (publ) (FN STO: PILA) announces that it will present today at the Redeye Theme: Diabetes.
CEO Gustav H. Gram increases holding in Pila Pharma AB Pila Pharma AB (publ) (FN STO: PILA) announces that newly appointed CEO Gustav H. Gram has purchased additional shares. The purchases occurred in two tranches: Friday May 10th, w...
PILA PHARMA RECEIVES AWARD OF INNOVATION GRANT Pila Pharma AB (publ) (FN STO: PILA) hereby informs that it has been awarded an innovation grant corresponding to a value of SEK 100.000 to sponsor a further developed IP strateg...
REMINDER: PILA PHARMA ABs NEXT FINANCIAL REPORT IS DUE IN AUGUST Pila Pharma AB (publ) (FN STO: PILA) hereby reminds, that the Company has transferred to half-year financial reporting and, thus, the Company's next financial report is due on 27...
REG MAR
PILA PHARMA AB APPOINTS NEW CHAIRMAN OF THE BOARD AND CEO Following the election yesterday of Dorte X. Gram as new Chairman of the Board of Pila Pharma AB (publ) (FN STO: PILA) she simultaneously has stepped down as CEO. The newly elect...
REG
KOMMUNIKE FRÅN ÅRSSTÄMMA I PILA PHARMA AB 2024 Pila Pharma AB (publ) höll på torsdagen den 18 april 2024 årsstämma hos MAQS Advokatbyrå, Gibraltargatan 7 i Malmö. Följande huvudsakliga beslut fattades:
PILA PHARMA TO PRESENT IN ODENSE, DENMARK & ONLINE PILA PHARMA AB (publ) (FN STO: PILA) hereby invites investors to participate in the below scheduled events in the next weeks:Redeye Online Investor Event (ONLINE / Stockholm, Swe...
CEO COMMENT ON NOMINATION TO BECOME NEXT CHAIRMAN Founder and CEO, Dorte X. Gram of PILA PHARMA AB (publ) (FN STO: PILA) comments on recent Company news that she is nominated to become the next Chairman of the Board. PILA PHARMA...
REG
KALLELSE TILL ÅRSSTÄMMA I PILA PHARMA AB Aktieägarna i PILA PHARMA AB, org.nr 556966-4831 ("PILA PHARMA" eller "Bolaget"), kallas härmed till årsstämma tisdag den 18 april 2024 kl. 15.00 hos MAQS Advokatbyrå, Gibraltarg...
REG
PILA PHARMA PUBLISHES THE ANNUAL REPORT 2023 PILA PHARMA AB (publ) (FN STO: PILA) announces that the annual report (in Swedish) is now available on the Company´s homepage, https://pilapharma.com/investors/finansiell-informa...
REG
PILA PHARMA ADVANCES THE PUBLICATION OF THE ANNUAL REPORT 2023 PILA PHARMA AB (publ) (FN STO: PILA) has decided to advance the publication of its annual report for the financial year ended 31 December 2023 to the 20 March 2024. The previous...
PILA PHARMA INVITES YOU TO INVESTOR MEETINGS PILA PHARMA AB (publ) (FN STO: PILA) hereby invites you to participate in these upcoming investor events:___________AktieInfo Investor Evening (Scandic Sydhavnen, Copenhagen, Den...
PILA PHARMA INVITES TO INVESTOR MEETING IN KOLDING, DENMARK PILA PHARMA AB (publ) (FN STO: PILA) hereby invites local Danish investors to participate in the event we organize together with the regional office of Danish Shareholders Associ...
PILA PHARMA INVITES TO ONLINE INVESTOR MEETING & EARNINGS CALL PILA PHARMA AB (publ) (FN STO: PILA) hereby invites you to an online session to discuss and comment the year-end report.
REG MAR
PILA PHARMA publishes year-end report (1 January - 31 December 2023) PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s year-end report for the period January - December 2023. The report can be found on the Company´s website: https...

Om PILA PHARMA

Prenumerera

Få löpande information från PILA PHARMA via e-post.

Handelsinformation

Kurs ()
Förändring ()
Marknad Nasdaq First North Growth Market Kortnamn PILA ISIN-kod SE0015988274 Certified Adviser Aqurat Fondkommission